This was the stock's third consecutive day of losses.

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) ...

Pfizer and Flagship Pioneering are turning to autoimmune disease as the sixth plank of their multibillion-dollar, 10-program ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

One of the most promising aspects of AI and its integration into the pharmaceutical industry is the technology’s potential to ...

Charles River Laboratories International Stock Down 5.7 % Shares of NYSE CRL opened at $140.79 on Friday. The stock has a 50-day moving average price of $163.05 and a two-hundred day moving ...

Learn more about whether Charles River Laboratories International, Inc. or Stevanato Group S.p.A. is a better investment ...

Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts ...

Goldman Sachs analyst Matthew Sykes downgraded Charles River (CRL) to Neutral from Buy with a price target of $170, down from $190. While the ...

Corebridge Financial Inc. lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.5% during the fourth quarter, according to its most recent disclosure ...

Charles River Laboratories International Inc. closed 46.74% short of its 52-week high of $264.71, which the company reached ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...